Literature DB >> 31026248

Melanoma Explorer: a web application to allow easy reanalysis of publicly available and clinically annotated melanoma omics data sets.

Dario Strbenac1, Kevin Wang1, Xinyue Wang1,2, Jiamin Dong1, Graham J Mann3,4, Samuel Mueller1, Jean Y H Yang1.   

Abstract

Validating newly discovered biomarkers in large, publicly available data sets is often difficult and requires specialized computer programming skills. Melanoma Explorer is a web application that enables easy interrogation of melanoma omics data sets that are freely available in online data repositories with a point-and-click interface. Two use cases are demonstrated. First, the relationship of lysozyme mRNA expression is shown to be prognostic in two independent gene expression microarray data sets. Second, a figure from a journal article showing the relationship of tumour thickness and miR-382 abundance is reproduced. Melanoma Explorer is demonstrated to be a useful tool for reproducing results of published studies and providing additional evidence for biomarkers in independent data sets.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31026248     DOI: 10.1097/CMR.0000000000000533

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  3 in total

1.  Genes regulated by DNA methylation are involved in distinct phenotypes during melanoma progression and are prognostic factors for patients.

Authors:  Debora D'Angelo Papaiz; Flávia Eichemberger Rius; Ana Luísa Pedroso Ayub; Clarice S Origassa; Hemant Gujar; Diogo de Oliveira Pessoa; Eduardo Moraes Reis; Jérémie Nsengimana; Julia Newton-Bishop; Christopher E Mason; Daniel J Weisenberger; Gangning Liang; Miriam Galvonas Jasiulionis
Journal:  Mol Oncol       Date:  2022-02-04       Impact factor: 7.449

2.  Cross-Platform Omics Prediction procedure: a statistical machine learning framework for wider implementation of precision medicine.

Authors:  Kevin Y X Wang; Gulietta M Pupo; Varsha Tembe; Ellis Patrick; Dario Strbenac; Sarah-Jane Schramm; John F Thompson; Richard A Scolyer; Samuel Muller; Garth Tarr; Graham J Mann; Jean Y H Yang
Journal:  NPJ Digit Med       Date:  2022-07-04

3.  miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients.

Authors:  Adriana Taveira da Cruz; Aline Hunger; Fabiana Henriques Machado de Melo; Ana Carolina Monteiro; Geneviève Catherine Paré; Dulce Lai; Débora Kristina Alves-Fernandes; Ana Luisa Pedroso Ayub; Esteban Mauricio Cordero; José Franco da Silveira Filho; Regine Schneider-Stock; Bryan Eric Strauss; Victor Tron; Miriam Galvonas Jasiulionis
Journal:  Neoplasia       Date:  2021-07-08       Impact factor: 5.715

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.